Global Peptide Antibiotics Market Insights and Forecast to 2026
- BMR3911169
- 115 Pages
- June 2020
- Healthcare
Prior to COVID-19, the market for Peptide Antibiotics was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Peptide Antibiotics is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Peptide Antibiotics market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Peptide Antibiotics market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Peptide Antibiotics industry.
Global Peptide Antibiotics Scope and Segment
Peptide Antibiotics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Peptide Antibiotics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Pfizer
Novartis
GlaxoSmithKline
Eli Lilly
Theravance
Vicuron Pharmaceuticals
Savara Pharmaceuticals
AMP Therapeutics
Hospira
Kasten
Madam Therapeutics
Phosphagenics
Pacgen Life Science Corporation
Peptide Antibiotics Breakdown Data by Type
Ribosomal Synthesized Peptide Antibiotics
Non-Ribosomally Synthesized Peptide Antibiotics
Peptide Antibiotics Breakdown Data by Application
Pharma & Healthcare
Food Industry
Commodities
Other
Regional and Country-level Analysis
The Peptide Antibiotics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Peptide Antibiotics market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Peptide Antibiotics Market Share Analysis
1.1 Peptide Antibiotics Product Introduction
1.2 Market Segments
1.3 Key Peptide Antibiotics Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Peptide Antibiotics Market Size Growth Rate by Type
1.4.2 Ribosomal Synthesized Peptide Antibiotics
1.4.3 Non-Ribosomally Synthesized Peptide Antibiotics
1.5 Market by Application
1.5.1 Global Peptide Antibiotics Market Size Growth Rate by Application
1.5.2 Pharma & Healthcare
1.5.3 Food Industry
1.5.4 Commodities
1.5.5 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Peptide Antibiotics Market Size, Estimates and Forecasts
2.1.1 Global Peptide Antibiotics Revenue 2015-2026
2.1.2 Global Peptide Antibiotics Sales 2015-2026
2.2 Global Peptide Antibiotics, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Peptide Antibiotics Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Peptide Antibiotics Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Peptide Antibiotics Competitor Landscape by Players
3.1 Peptide Antibiotics Sales by Manufacturers
3.1.1 Peptide Antibiotics Sales by Manufacturers (2015-2020)
3.1.2 Peptide Antibiotics Sales Market Share by Manufacturers (2015-2020)
3.2 Peptide Antibiotics Revenue by Manufacturers
3.2.1 Peptide Antibiotics Revenue by Manufacturers (2015-2020)
3.2.2 Peptide Antibiotics Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Peptide Antibiotics Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Peptide Antibiotics Revenue in 2019
3.2.5 Global Peptide Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Peptide Antibiotics Price by Manufacturers
3.4 Peptide Antibiotics Manufacturing Base Distribution, Product Types
3.4.1 Peptide Antibiotics Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Peptide Antibiotics Product Type
3.4.3 Date of International Manufacturers Enter into Peptide Antibiotics Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Peptide Antibiotics Market Size by Type (2015-2020)
4.1.1 Global Peptide Antibiotics Sales by Type (2015-2020)
4.1.2 Global Peptide Antibiotics Revenue by Type (2015-2020)
4.1.3 Peptide Antibiotics Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Peptide Antibiotics Market Size Forecast by Type (2021-2026)
4.2.1 Global Peptide Antibiotics Sales Forecast by Type (2021-2026)
4.2.2 Global Peptide Antibiotics Revenue Forecast by Type (2021-2026)
4.2.3 Peptide Antibiotics Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Peptide Antibiotics Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Peptide Antibiotics Market Size by Application (2015-2020)
5.1.1 Global Peptide Antibiotics Sales by Application (2015-2020)
5.1.2 Global Peptide Antibiotics Revenue by Application (2015-2020)
5.1.3 Peptide Antibiotics Price by Application (2015-2020)
5.2 Peptide Antibiotics Market Size Forecast by Application (2021-2026)
5.2.1 Global Peptide Antibiotics Sales Forecast by Application (2021-2026)
5.2.2 Global Peptide Antibiotics Revenue Forecast by Application (2021-2026)
5.2.3 Global Peptide Antibiotics Price Forecast by Application (2021-2026)
6 North America
6.1 North America Peptide Antibiotics by Country
6.1.1 North America Peptide Antibiotics Sales by Country
6.1.2 North America Peptide Antibiotics Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Peptide Antibiotics Market Facts & Figures by Type
6.3 North America Peptide Antibiotics Market Facts & Figures by Application
7 Europe
7.1 Europe Peptide Antibiotics by Country
7.1.1 Europe Peptide Antibiotics Sales by Country
7.1.2 Europe Peptide Antibiotics Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Peptide Antibiotics Market Facts & Figures by Type
7.3 Europe Peptide Antibiotics Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Peptide Antibiotics by Region
8.1.1 Asia Pacific Peptide Antibiotics Sales by Region
8.1.2 Asia Pacific Peptide Antibiotics Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Peptide Antibiotics Market Facts & Figures by Type
8.3 Asia Pacific Peptide Antibiotics Market Facts & Figures by Application
9 Latin America
9.1 Latin America Peptide Antibiotics by Country
9.1.1 Latin America Peptide Antibiotics Sales by Country
9.1.2 Latin America Peptide Antibiotics Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Peptide Antibiotics Market Facts & Figures by Type
9.3 Central & South America Peptide Antibiotics Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Peptide Antibiotics by Country
10.1.1 Middle East and Africa Peptide Antibiotics Sales by Country
10.1.2 Middle East and Africa Peptide Antibiotics Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Peptide Antibiotics Market Facts & Figures by Type
10.3 Middle East and Africa Peptide Antibiotics Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Peptide Antibiotics Products Offered
11.1.5 Pfizer Related Developments
11.2 Novartis
11.2.1 Novartis Corporation Information
11.2.2 Novartis Description and Business Overview
11.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Novartis Peptide Antibiotics Products Offered
11.2.5 Novartis Related Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Corporation Information
11.3.2 GlaxoSmithKline Description and Business Overview
11.3.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GlaxoSmithKline Peptide Antibiotics Products Offered
11.3.5 GlaxoSmithKline Related Developments
11.4 Eli Lilly
11.4.1 Eli Lilly Corporation Information
11.4.2 Eli Lilly Description and Business Overview
11.4.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Eli Lilly Peptide Antibiotics Products Offered
11.4.5 Eli Lilly Related Developments
11.5 Theravance
11.5.1 Theravance Corporation Information
11.5.2 Theravance Description and Business Overview
11.5.3 Theravance Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Theravance Peptide Antibiotics Products Offered
11.5.5 Theravance Related Developments
11.6 Vicuron Pharmaceuticals
11.6.1 Vicuron Pharmaceuticals Corporation Information
11.6.2 Vicuron Pharmaceuticals Description and Business Overview
11.6.3 Vicuron Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Vicuron Pharmaceuticals Peptide Antibiotics Products Offered
11.6.5 Vicuron Pharmaceuticals Related Developments
11.7 Savara Pharmaceuticals
11.7.1 Savara Pharmaceuticals Corporation Information
11.7.2 Savara Pharmaceuticals Description and Business Overview
11.7.3 Savara Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Savara Pharmaceuticals Peptide Antibiotics Products Offered
11.7.5 Savara Pharmaceuticals Related Developments
11.8 AMP Therapeutics
11.8.1 AMP Therapeutics Corporation Information
11.8.2 AMP Therapeutics Description and Business Overview
11.8.3 AMP Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.8.4 AMP Therapeutics Peptide Antibiotics Products Offered
11.8.5 AMP Therapeutics Related Developments
11.9 Hospira
11.9.1 Hospira Corporation Information
11.9.2 Hospira Description and Business Overview
11.9.3 Hospira Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Hospira Peptide Antibiotics Products Offered
11.9.5 Hospira Related Developments
11.10 Kasten
11.10.1 Kasten Corporation Information
11.10.2 Kasten Description and Business Overview
11.10.3 Kasten Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Kasten Peptide Antibiotics Products Offered
11.10.5 Kasten Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Peptide Antibiotics Products Offered
11.1.5 Pfizer Related Developments
11.12 Phosphagenics
11.12.1 Phosphagenics Corporation Information
11.12.2 Phosphagenics Description and Business Overview
11.12.3 Phosphagenics Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Phosphagenics Products Offered
11.12.5 Phosphagenics Related Developments
11.13 Pacgen Life Science Corporation
11.13.1 Pacgen Life Science Corporation Corporation Information
11.13.2 Pacgen Life Science Corporation Description and Business Overview
11.13.3 Pacgen Life Science Corporation Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Pacgen Life Science Corporation Products Offered
11.13.5 Pacgen Life Science Corporation Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Peptide Antibiotics Market Estimates and Projections by Region
12.1.1 Global Peptide Antibiotics Sales Forecast by Regions 2021-2026
12.1.2 Global Peptide Antibiotics Revenue Forecast by Regions 2021-2026
12.2 North America Peptide Antibiotics Market Size Forecast (2021-2026)
12.2.1 North America: Peptide Antibiotics Sales Forecast (2021-2026)
12.2.2 North America: Peptide Antibiotics Revenue Forecast (2021-2026)
12.2.3 North America: Peptide Antibiotics Market Size Forecast by Country (2021-2026)
12.3 Europe Peptide Antibiotics Market Size Forecast (2021-2026)
12.3.1 Europe: Peptide Antibiotics Sales Forecast (2021-2026)
12.3.2 Europe: Peptide Antibiotics Revenue Forecast (2021-2026)
12.3.3 Europe: Peptide Antibiotics Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Peptide Antibiotics Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Peptide Antibiotics Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Peptide Antibiotics Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Peptide Antibiotics Market Size Forecast by Region (2021-2026)
12.5 Latin America Peptide Antibiotics Market Size Forecast (2021-2026)
12.5.1 Latin America: Peptide Antibiotics Sales Forecast (2021-2026)
12.5.2 Latin America: Peptide Antibiotics Revenue Forecast (2021-2026)
12.5.3 Latin America: Peptide Antibiotics Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Peptide Antibiotics Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Peptide Antibiotics Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Peptide Antibiotics Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Peptide Antibiotics Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Peptide Antibiotics Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Peptide Antibiotics Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Peptide Antibiotics Market Segments
Table 2. Ranking of Global Top Peptide Antibiotics Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Peptide Antibiotics Market Size Growth Rate by Type 2020-2026 (MT) & (US$ Million)
Table 4. Major Manufacturers of Ribosomal Synthesized Peptide Antibiotics
Table 5. Major Manufacturers of Non-Ribosomally Synthesized Peptide Antibiotics
Table 6. Global Peptide Antibiotics Market Size Growth Rate by Application 2020-2026 (MT)
Table 7. Global Peptide Antibiotics Market Size by Region (MT) & (US$ Million): 2020 VS 2026
Table 8. Global Peptide Antibiotics Sales by Regions 2015-2020 (MT)
Table 9. Global Peptide Antibiotics Sales Market Share by Regions (2015-2020)
Table 10. Global Peptide Antibiotics Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Peptide Antibiotics Sales by Manufacturers (2015-2020) (MT)
Table 12. Global Peptide Antibiotics Sales Share by Manufacturers (2015-2020)
Table 13. Global Peptide Antibiotics Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Peptide Antibiotics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Antibiotics as of 2019)
Table 15. Peptide Antibiotics Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Peptide Antibiotics Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Peptide Antibiotics Price (2015-2020) (USD/Kg)
Table 18. Peptide Antibiotics Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Peptide Antibiotics Product Type
Table 20. Date of International Manufacturers Enter into Peptide Antibiotics Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Peptide Antibiotics Sales by Type (2015-2020) (MT)
Table 23. Global Peptide Antibiotics Sales Share by Type (2015-2020)
Table 24. Global Peptide Antibiotics Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Peptide Antibiotics Revenue Share by Type (2015-2020)
Table 26. Peptide Antibiotics Average Selling Price (ASP) by Type 2015-2020 (USD/Kg)
Table 27. Global Peptide Antibiotics Sales by Application (2015-2020) (MT)
Table 28. Global Peptide Antibiotics Sales Share by Application (2015-2020)
Table 29. North America Peptide Antibiotics Sales by Country (2015-2020) (MT)
Table 30. North America Peptide Antibiotics Sales Market Share by Country (2015-2020)
Table 31. North America Peptide Antibiotics Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Peptide Antibiotics Revenue Market Share by Country (2015-2020)
Table 33. North America Peptide Antibiotics Sales by Type (2015-2020) (MT)
Table 34. North America Peptide Antibiotics Sales Market Share by Type (2015-2020)
Table 35. North America Peptide Antibiotics Sales by Application (2015-2020) (MT)
Table 36. North America Peptide Antibiotics Sales Market Share by Application (2015-2020)
Table 37. Europe Peptide Antibiotics Sales by Country (2015-2020) (MT)
Table 38. Europe Peptide Antibiotics Sales Market Share by Country (2015-2020)
Table 39. Europe Peptide Antibiotics Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Peptide Antibiotics Revenue Market Share by Country (2015-2020)
Table 41. Europe Peptide Antibiotics Sales by Type (2015-2020) (MT)
Table 42. Europe Peptide Antibiotics Sales Market Share by Type (2015-2020)
Table 43. Europe Peptide Antibiotics Sales by Application (2015-2020) (MT)
Table 44. Europe Peptide Antibiotics Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Peptide Antibiotics Sales by Region (2015-2020) (MT)
Table 46. Asia Pacific Peptide Antibiotics Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Peptide Antibiotics Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Peptide Antibiotics Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Peptide Antibiotics Sales by Type (2015-2020) (MT)
Table 50. Asia Pacific Peptide Antibiotics Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Peptide Antibiotics Sales by Application (2015-2020) (MT)
Table 52. Asia Pacific Peptide Antibiotics Sales Market Share by Application (2015-2020)
Table 53. Latin America Peptide Antibiotics Sales by Country (2015-2020) (MT)
Table 54. Latin America Peptide Antibiotics Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Peptide Antibiotics Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Peptide Antibiotics Revenue Market Share by Country (2015-2020)
Table 57. Latin America Peptide Antibiotics Sales by Type (2015-2020) (MT)
Table 58. Latin America Peptide Antibiotics Sales Market Share by Type (2015-2020)
Table 59. Latin America Peptide Antibiotics Sales by Application (2015-2020) (MT)
Table 60. Latin America Peptide Antibiotics Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Peptide Antibiotics Sales by Country (2015-2020) (MT)
Table 62. Middle East and Africa Peptide Antibiotics Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Peptide Antibiotics Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Peptide Antibiotics Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Peptide Antibiotics Sales by Type (2015-2020) (MT)
Table 66. Middle East and Africa Peptide Antibiotics Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Peptide Antibiotics Sales by Application (2015-2020) (MT)
Table 68. Middle East and Africa Peptide Antibiotics Sales Market Share by Application (2015-2020)
Table 69. Pfizer Corporation Information
Table 70. Pfizer Description and Major Businesses
Table 71. Pfizer Peptide Antibiotics Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 72. Pfizer Product
Table 73. Pfizer Recent Development
Table 74. Novartis Corporation Information
Table 75. Novartis Description and Major Businesses
Table 76. Novartis Peptide Antibiotics Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 77. Novartis Product
Table 78. Novartis Recent Development
Table 79. GlaxoSmithKline Corporation Information
Table 80. GlaxoSmithKline Description and Major Businesses
Table 81. GlaxoSmithKline Peptide Antibiotics Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 82. GlaxoSmithKline Product
Table 83. GlaxoSmithKline Recent Development
Table 84. Eli Lilly Corporation Information
Table 85. Eli Lilly Description and Major Businesses
Table 86. Eli Lilly Peptide Antibiotics Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 87. Eli Lilly Product
Table 88. Eli Lilly Recent Development
Table 89. Theravance Corporation Information
Table 90. Theravance Description and Major Businesses
Table 91. Theravance Peptide Antibiotics Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 92. Theravance Product
Table 93. Theravance Recent Development
Table 94. Vicuron Pharmaceuticals Corporation Information
Table 95. Vicuron Pharmaceuticals Description and Major Businesses
Table 96. Vicuron Pharmaceuticals Peptide Antibiotics Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 97. Vicuron Pharmaceuticals Product
Table 98. Vicuron Pharmaceuticals Recent Development
Table 99. Savara Pharmaceuticals Corporation Information
Table 100. Savara Pharmaceuticals Description and Major Businesses
Table 101. Savara Pharmaceuticals Peptide Antibiotics Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 102. Savara Pharmaceuticals Product
Table 103. Savara Pharmaceuticals Recent Development
Table 104. AMP Therapeutics Corporation Information
Table 105. AMP Therapeutics Description and Major Businesses
Table 106. AMP Therapeutics Peptide Antibiotics Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 107. AMP Therapeutics Product
Table 108. AMP Therapeutics Recent Development
Table 109. Hospira Corporation Information
Table 110. Hospira Description and Major Businesses
Table 111. Hospira Peptide Antibiotics Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. Hospira Product
Table 113. Hospira Recent Development
Table 114. Kasten Corporation Information
Table 115. Kasten Description and Major Businesses
Table 116. Kasten Peptide Antibiotics Production (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. Kasten Product
Table 118. Kasten Recent Development
Table 119. Madam Therapeutics Corporation Information
Table 120. Madam Therapeutics Description and Major Businesses
Table 121. Madam Therapeutics Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. Madam Therapeutics Product
Table 123. Madam Therapeutics Recent Development
Table 124. Phosphagenics Corporation Information
Table 125. Phosphagenics Description and Major Businesses
Table 126. Phosphagenics Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 127. Phosphagenics Product
Table 128. Phosphagenics Recent Development
Table 129. Pacgen Life Science Corporation Corporation Information
Table 130. Pacgen Life Science Corporation Description and Major Businesses
Table 131. Pacgen Life Science Corporation Peptide Antibiotics Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2015-2020)
Table 132. Pacgen Life Science Corporation Product
Table 133. Pacgen Life Science Corporation Recent Development
Table 134. Global Peptide Antibiotics Sales Forecast by Regions (2021-2026) (MT)
Table 135. Global Peptide Antibiotics Sales Market Share Forecast by Regions (2021-2026)
Table 136. Global Peptide Antibiotics Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 137. Global Peptide Antibiotics Revenue Market Share Forecast by Regions (2021-2026)
Table 138. North America: Peptide Antibiotics Sales Forecast by Country (2021-2026) (MT)
Table 139. North America: Peptide Antibiotics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Europe: Peptide Antibiotics Sales Forecast by Country (2021-2026) (MT)
Table 141. Europe: Peptide Antibiotics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Asia Pacific: Peptide Antibiotics Sales Forecast by Region (2021-2026) (MT)
Table 143. Asia Pacific: Peptide Antibiotics Revenue Forecast by Region (2021-2026) (US$ Million)
Table 144. Latin America: Peptide Antibiotics Sales Forecast by Country (2021-2026) (MT)
Table 145. Latin America: Peptide Antibiotics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 146. Middle East and Africa: Peptide Antibiotics Sales Forecast by Country (2021-2026) (MT)
Table 147. Middle East and Africa: Peptide Antibiotics Revenue Forecast by Country (2021-2026) (US$ Million)
Table 148. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 149. Key Challenges
Table 150. Market Risks
Table 151. Main Points Interviewed from Key Peptide Antibiotics Players
Table 152. Peptide Antibiotics Customers List
Table 153. Peptide Antibiotics Distributors List
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptide Antibiotics Product Picture
Figure 2. Global Peptide Antibiotics Sales Market Share by Type in 2020 & 2026
Figure 3. Ribosomal Synthesized Peptide Antibiotics Product Picture
Figure 4. Non-Ribosomally Synthesized Peptide Antibiotics Product Picture
Figure 5. Global Peptide Antibiotics Sales Market Share by Application in 2020 & 2026
Figure 6. Pharma & Healthcare
Figure 7. Food Industry
Figure 8. Commodities
Figure 9. Other
Figure 10. Peptide Antibiotics Report Years Considered
Figure 11. Global Peptide Antibiotics Market Size 2015-2026 (US$ Million)
Figure 12. Global Peptide Antibiotics Sales 2015-2026 (MT)
Figure 13. Global Peptide Antibiotics Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Peptide Antibiotics Sales Market Share by Region (2015-2020)
Figure 15. Global Peptide Antibiotics Sales Market Share by Region in 2019
Figure 16. Global Peptide Antibiotics Revenue Market Share by Region (2015-2020)
Figure 17. Global Peptide Antibiotics Revenue Market Share by Region in 2019
Figure 18. Global Peptide Antibiotics Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Peptide Antibiotics Revenue in 2019
Figure 20. Peptide Antibiotics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Peptide Antibiotics Sales Market Share by Type (2015-2020)
Figure 22. Global Peptide Antibiotics Sales Market Share by Type in 2019
Figure 23. Global Peptide Antibiotics Revenue Market Share by Type (2015-2020)
Figure 24. Global Peptide Antibiotics Revenue Market Share by Type in 2019
Figure 25. Global Peptide Antibiotics Market Share by Price Range (2015-2020)
Figure 26. Global Peptide Antibiotics Sales Market Share by Application (2015-2020)
Figure 27. Global Peptide Antibiotics Sales Market Share by Application in 2019
Figure 28. Global Peptide Antibiotics Revenue Market Share by Application (2015-2020)
Figure 29. Global Peptide Antibiotics Revenue Market Share by Application in 2019
Figure 30. North America Peptide Antibiotics Sales Growth Rate 2015-2020 (MT)
Figure 31. North America Peptide Antibiotics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Peptide Antibiotics Sales Market Share by Country in 2019
Figure 33. North America Peptide Antibiotics Revenue Market Share by Country in 2019
Figure 34. U.S. Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 35. U.S. Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 37. Canada Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Peptide Antibiotics Market Share by Type in 2019
Figure 39. North America Peptide Antibiotics Market Share by Application in 2019
Figure 40. Europe Peptide Antibiotics Sales Growth Rate 2015-2020 (MT)
Figure 41. Europe Peptide Antibiotics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Peptide Antibiotics Sales Market Share by Country in 2019
Figure 43. Europe Peptide Antibiotics Revenue Market Share by Country in 2019
Figure 44. Germany Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 45. Germany Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 47. France Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 49. U.K. Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 51. Italy Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 53. Russia Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Peptide Antibiotics Market Share by Type in 2019
Figure 55. Europe Peptide Antibiotics Market Share by Application in 2019
Figure 56. Asia Pacific Peptide Antibiotics Sales Growth Rate 2015-2020 (MT)
Figure 57. Asia Pacific Peptide Antibiotics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Peptide Antibiotics Sales Market Share by Region in 2019
Figure 59. Asia Pacific Peptide Antibiotics Revenue Market Share by Region in 2019
Figure 60. China Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 61. China Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 63. Japan Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 65. South Korea Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 67. India Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 69. Australia Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 71. Taiwan Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 73. Indonesia Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 75. Thailand Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 77. Malaysia Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 79. Philippines Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 81. Vietnam Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Peptide Antibiotics Market Share by Type in 2019
Figure 83. Asia Pacific Peptide Antibiotics Market Share by Application in 2019
Figure 84. Latin America Peptide Antibiotics Sales Growth Rate 2015-2020 (MT)
Figure 85. Latin America Peptide Antibiotics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Peptide Antibiotics Sales Market Share by Country in 2019
Figure 87. Latin America Peptide Antibiotics Revenue Market Share by Country in 2019
Figure 88. Mexico Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 89. Mexico Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 91. Brazil Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 93. Argentina Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Peptide Antibiotics Market Share by Type in 2019
Figure 95. Latin America Peptide Antibiotics Market Share by Application in 2019
Figure 96. Middle East and Africa Peptide Antibiotics Sales Growth Rate 2015-2020 (MT)
Figure 97. Middle East and Africa Peptide Antibiotics Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Peptide Antibiotics Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Peptide Antibiotics Revenue Market Share by Country in 2019
Figure 100. Turkey Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 101. Turkey Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 103. Saudi Arabia Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Peptide Antibiotics Sales Growth Rate (2015-2020) (MT)
Figure 105. U.A.E Peptide Antibiotics Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Peptide Antibiotics Market Share by Type in 2019
Figure 107. Middle East and Africa Peptide Antibiotics Market Share by Application in 2019
Figure 108. North America Peptide Antibiotics Sales Growth Rate Forecast (2021-2026) (MT)
Figure 109. North America Peptide Antibiotics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Peptide Antibiotics Sales Growth Rate Forecast (2021-2026) (MT)
Figure 111. Europe Peptide Antibiotics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Peptide Antibiotics Sales Growth Rate Forecast (2021-2026) (MT)
Figure 113. Asia Pacific Peptide Antibiotics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Peptide Antibiotics Sales Growth Rate Forecast (2021-2026) (MT)
Figure 115. Latin America Peptide Antibiotics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Peptide Antibiotics Sales Growth Rate Forecast (2021-2026) (MT)
Figure 117. Middle East and Africa Peptide Antibiotics Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
